Skip to main content

Table 1 Summary of reported cases of mucinous cystic neoplasm of pancreas with sarcomatous component

From: Pancreatic mucinous cystic neoplasm with sarcomatous stroma metastasizing to liver: a case report and review of literature

Reference

Demographic features

Epithelial component

Sarcomatous component

 

Age

Sex

Histology

Histology

Immunohistochemistry findings

[8]

48

M

MCN, carcinosarcoma

Pleomorphism, high-grade atypia, atypical mitosis, necrosis

Vimentin (+)

ER, PR (−)

Liver and lymph node metastasis of carcinoma

S100 (−)

CD34 (−)

SMA (−)

[9]

70

F

MCN, invasive adenocarcinoma

Spindle cell sarcoma

Vimentin (+)

Mucin 1 (+)

[10]

67

F

MCN, invasive adenocarcinoma

Pleomorphic sarcoma

Vimentin (+)

Moderate to high-grade atypia

S100 (−)

Atypical mitosis

c-Kit (−)

Metastasis to liver

 

[3]

30

F

MCN

MCN with mesenchymal overgrowth

ER, PR (+)

Mild atypia, low number of mitoses

No metastasis

[11]

48

F

MCN with atypia

MCN with sarcomatous stroma

Vimentin, MSA, SMA

ER and PR (+)

66

F

MCN with atypia

MCN with sarcomatous stroma

Vimentin,

Moderate to high-grade atypia

MSA, SMA,

Numerous mitoses

S100 (variable),

Distant metastasis

ER and PR (+)

67

M

MCN, invasive adenocarcinoma

MCN with sarcomatous stroma

Vimentin,

MSA, SMA,

Moderate to high-grade atypia

S100 (+)

ER and PR (−)

Numerous mitoses

Omental metastasis

[5]

43

F

MCN

MFH

Vimentin, lysozyme, α1 antitrypsin

[4]

45

F

MCN

Pseudosarcomatous, mural nodules

CK, EMA, Vimentin

  1. ER, estrogen receptor; MCN, mucinous cystic neoplasm; MFH, malignant fibrous histiocytoma; MSA, muscle-specific actin; PR, progesterone receptor; SMA, smooth muscle actin.